US Stock MarketDetailed Quotes

BLRX BioLine Rx

Watchlist
  • 0.278
  • -0.045-13.97%
Close Nov 22 16:00 ET
  • 0.279
  • +0.001+0.32%
Post 20:01 ET
23.39MMarket Cap-613P/E (TTM)

BioLine Rx Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

BioLine Rx Q3 2024 Estimates Date

Currency：USDNov 25, 2024

Estimate YoY
Revenue
5.29M
--
EPS
-0.07
+76.69%
Analyst Rating
Buy

Oct 31, 2024

BioLine Rx Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 6.211M--
Nov 25, 20242024/Q3-- / 5.290M--
Aug 15, 20242024/Q25.393M / 2.940M--
May 28, 20242024/Q16.855M / 340.000K--
Mar 26, 20242023/Q44.800M / 165.000K--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 6.211M--
Nov 25, 20242024/Q3-- / 5.290M--
Aug 15, 20242024/Q25.393M / 2.940M--
May 28, 20242024/Q16.855M / 340.000K--
Mar 26, 20242023/Q44.800M / 165.000K--

Unlock Free Earnings Estimates

BioLine Rx Earnings Reports

  • BioLine Rx | 6-K: Report of foreign private issuer (related to financial reporting)

    Nov 21 06:54 ET

  • BioLine Rx | 6-K: Report of foreign private issuer (related to financial reporting)

    Aug 19 16:36 ET

  • BioLine Rx | 6-K: Report of foreign private issuer (related to financial reporting)

    Aug 15 07:12 ET

  • BioLine Rx | 6-K: Report of foreign private issuer (related to financial reporting)

    May 28 07:16 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Oct 31, 2024

    Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data